Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines
0 sources
Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines
Summary
Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines is a doctoral thesis[1].
Key Facts
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines authored Katrin Kramer[2].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's instance of is recorded as doctoral thesis[3].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's publisher is recorded as OUR Archive[4].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's language of work or name is recorded as English[5].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's country of origin is recorded as New Zealand[6].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's publication date is recorded as +2016-00-00T00:00:00Z[7].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's main subject is recorded as immunotherapy[8].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's main subject is recorded as vaccine[9].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's work available at URL is recorded as https://ourarchive.otago.ac.nz/handle/10523/6772[10].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's Handle ID is recorded as 10523/6772[11].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's title is recorded as Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines[12].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's copyright holder is recorded as Katrin Kramer[13].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's thesis submitted to is recorded as University of Otago[14].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's on focus list of Wikimedia project is recorded as NZThesisProject[15].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's copyright status is recorded as copyrighted[16].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's thesis committee member is recorded as Greg Walker[17].
- Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's thesis committee member is recorded as Sarah Louise Young[18].
Body
Designation and Status
Bio-conjugate Approaches for Improved Targeted Toll-like receptor based Immune Adjuvant Vaccines's instance of is recorded as doctoral thesis[3].